Inspire Corporate Bond ETF (IBD)
ETF ยท NYSE Arca
Inspire Corporate Bond ETF (IBD) is an exchange-traded fund listed on NYSE Arca, where it has traded since July 10, 2017.
- Type
- Exchange-traded fund
- Listed On
- NYSE Arca
- Listed Since
- July 10, 2017
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 110 institutions reported holding IBD, with 15.0 million shares worth $357.1 million in aggregate. The largest reported holder was Inspire Advisors, with 4.1 million shares worth $97.5 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Inspire Advisors | 4,102,463 | $98M | Reduced 5.21% |
| Faithward Advisors | 1,715,901 | $41M | Added 3.26% |
| Creative Financial Designs Inc /Adv | 968,280 | $23M | Reduced 8.35% |
| Lpl Financial | 823,286 | $20M | Added 33.76% |
| Bare Financial Services | 795,094 | $19M | Added 3.28% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is IBD?
Inspire Corporate Bond ETF (IBD) is an exchange-traded fund listed on NYSE Arca, where it has traded since July 10, 2017.
Who are the largest institutional holders of IBD?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of IBD were Inspire Advisors, Faithward Advisors and Creative Financial Designs Inc /Adv.
How many institutions own IBD?
110 institutions reported a position in IBD for the quarter ended June 30, 2026, worth $357.1 million in total.
Did institutions buy or sell IBD last quarter?
Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for IBD.
Every reported institutional holder, plus insider and congressional trades in IBD, on SentiSense.